CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, a privately-held biopharmaceutical company developing novel medicines based on its proprietary synthetic biology and microbiome platform, today announced that J.C. Gutiérrez-Ramos, Ph.D., Chief Executive Officer of Synlogic will present at a company overview session at the 34th Annual J.P. Morgan Healthcare Conference.
